Case Report: Efficient Avoidance of Hospitalization for Diabetic Ketosis Utilizing Technosphere Inhaled Insulin

Abstract

We describe the use of inhaled insulin for the therapy of diabetic ketosis/ketoacidosis in a patient with type 1 diabetes. In this situation high insulin levels are needed to metabolize ketone bodies and avoid hospitalization. Technosphere inhaled insulin (TI) may be an alternative to subcutaneously injected fast-acting insulins, not only because of its rapid onset of action but also lack of stacking leading to late-onset hypoglycemia. In conclusion, TI may well be more efficacious and safer in the outpatient management of diabetic ketosis/ketoacidosis than standard subcutaneously injected rapid-acting insulin.